NO20054034D0 - Fremgangsmate for behandling av hypotyroidisme. - Google Patents
Fremgangsmate for behandling av hypotyroidisme.Info
- Publication number
- NO20054034D0 NO20054034D0 NO20054034A NO20054034A NO20054034D0 NO 20054034 D0 NO20054034 D0 NO 20054034D0 NO 20054034 A NO20054034 A NO 20054034A NO 20054034 A NO20054034 A NO 20054034A NO 20054034 D0 NO20054034 D0 NO 20054034D0
- Authority
- NO
- Norway
- Prior art keywords
- hypothyroidism
- procedures
- treatment
- Prior art date
Links
- 208000003532 hypothyroidism Diseases 0.000 title 1
- 230000002989 hypothyroidism Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/364,800 US20040156893A1 (en) | 2003-02-11 | 2003-02-11 | Method for treating hypothyroidism |
PCT/US2004/003620 WO2004071432A2 (en) | 2003-02-11 | 2004-02-06 | Method for treating hypothyroidism |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20054034D0 true NO20054034D0 (no) | 2005-08-30 |
NO20054034L NO20054034L (no) | 2005-10-05 |
Family
ID=32824502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20054034A NO20054034L (no) | 2003-02-11 | 2005-08-30 | Fremgangsmate for behandling av hypotyroidisme. |
Country Status (9)
Country | Link |
---|---|
US (2) | US20040156893A1 (no) |
EP (1) | EP1599193A4 (no) |
JP (1) | JP2006517588A (no) |
AU (1) | AU2004211961B2 (no) |
BR (1) | BRPI0407410A (no) |
CA (1) | CA2515400A1 (no) |
CO (1) | CO5650242A2 (no) |
NO (1) | NO20054034L (no) |
WO (1) | WO2004071432A2 (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20022394A1 (it) | 2002-11-13 | 2004-05-14 | Bracco Spa | Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche. |
ITMI20110713A1 (it) | 2011-04-29 | 2012-10-30 | Bracco Imaging Spa | Processo per la preparazione di un derivato solfatato di3,5-diiodo-o-[3-iodofenil]-l-tirosina |
US10150792B2 (en) | 2010-11-08 | 2018-12-11 | Synthonics, Inc. | Bismuth-containing compounds, coordination polymers, methods for modulating pharmacokinetic properties of biologically active agents, and methods for treating patients |
US10695309B2 (en) | 2017-03-31 | 2020-06-30 | Western New England University | Sustained-release liothyronine formulations, method of preparation and method of use thereof |
EP4153135A1 (en) * | 2020-05-21 | 2023-03-29 | Equilibrate Therapeutics, LLC | Microneedle device for control of thyroid hormone levels |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3477954A (en) * | 1966-06-29 | 1969-11-11 | Armour Pharma | Phosphonium iodide complexes of thyroxine,methods of preparing same,and methods of preparing 3,5,3'-l-triiodothyronine therefrom |
US3577535A (en) * | 1966-06-29 | 1971-05-04 | Armour Pharma | Treatment of thyroid hormone impairment pharmaceutical compositions containing 3,5,3' -l-triiodothyronine complexes |
US3621096A (en) * | 1969-04-03 | 1971-11-16 | Univ North Carolina | Antidepressant method and composition for same comprising a tricyclic antidepressant and a thyroid hormone |
US3689669A (en) * | 1970-10-09 | 1972-09-05 | Univ Of North Carolina The | Antidepressant method and composition |
US3928553A (en) * | 1972-03-23 | 1975-12-23 | Univ New York | Radioimmunoassay method for triiodothyronine and thyroxine |
US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
GB8613688D0 (en) * | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
US5158978A (en) * | 1990-02-05 | 1992-10-27 | British Technology Group (U.S.A.) | Thyroid hormone treatment of acute cardiovascular compromise |
ATE164063T1 (de) * | 1991-12-30 | 1998-04-15 | Akzo Nobel Nv | Thyroaktive zusammensetzung mit kontrollierter freigabe |
US5571840A (en) * | 1993-06-22 | 1996-11-05 | The Regents Of The University Of Michigan | Method for treating central nervous system ischemia |
US6288117B1 (en) * | 2000-03-23 | 2001-09-11 | North Shore-Long Island Jewish Research Institute | Method for treating congestive heart failure |
US20020183882A1 (en) * | 2000-10-20 | 2002-12-05 | Michael Dearing | RF point of sale and delivery method and system using communication with remote computer and having features to read a large number of RF tags |
US20030194437A1 (en) * | 2001-08-14 | 2003-10-16 | Franz G. Andrew | Levothyroxine compositions having unique triiodothyronine Cmax properties |
-
2003
- 2003-02-11 US US10/364,800 patent/US20040156893A1/en not_active Abandoned
-
2004
- 2004-02-06 JP JP2006503412A patent/JP2006517588A/ja active Pending
- 2004-02-06 WO PCT/US2004/003620 patent/WO2004071432A2/en active Application Filing
- 2004-02-06 BR BRPI0407410-6A patent/BRPI0407410A/pt not_active IP Right Cessation
- 2004-02-06 CA CA002515400A patent/CA2515400A1/en not_active Abandoned
- 2004-02-06 EP EP04709106A patent/EP1599193A4/en not_active Withdrawn
- 2004-02-06 AU AU2004211961A patent/AU2004211961B2/en not_active Ceased
- 2004-09-24 US US10/949,722 patent/US20050176829A1/en not_active Abandoned
-
2005
- 2005-08-25 CO CO05084787A patent/CO5650242A2/es not_active Application Discontinuation
- 2005-08-30 NO NO20054034A patent/NO20054034L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0407410A (pt) | 2006-02-21 |
WO2004071432A2 (en) | 2004-08-26 |
CA2515400A1 (en) | 2004-08-26 |
AU2004211961A1 (en) | 2004-08-26 |
CO5650242A2 (es) | 2006-06-30 |
AU2004211961B2 (en) | 2009-04-23 |
EP1599193A2 (en) | 2005-11-30 |
US20050176829A1 (en) | 2005-08-11 |
JP2006517588A (ja) | 2006-07-27 |
WO2004071432A3 (en) | 2005-03-10 |
US20040156893A1 (en) | 2004-08-12 |
NO20054034L (no) | 2005-10-05 |
EP1599193A4 (en) | 2007-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20053211D0 (no) | Forbindelser for behandling av metabolske forstyrrelser. | |
AP2378A (en) | Sulfonamide derivatives for the treatment of diseases. | |
AP2359A (en) | Sulfonamide derivatives for the treatment of diseases. | |
AP2006003525A0 (en) | Ä1,8ÜNapthyridin-2-ones and related compounds for the treatment of schizophrenia. | |
NO20052058D0 (no) | Behandling av influensa. | |
NO20053041D0 (no) | Behandling av diabetes. | |
IS2722B (is) | 1, 2, 3, 4- Tetrasetin indól til meðhöndlunar á öndunarfærasjúkdómum | |
NO20035156D0 (no) | Fremgangsmåter for brönnbehandling | |
NO20053947D0 (no) | Forbedrede antitumorale behandlinger. | |
LTC2805723I2 (lt) | Kladribino režimas, skirtas išsėtinei sklerozei gydyti | |
DK1499730T3 (da) | Immunokonjugater til behandling af tumorer | |
NO20045554L (no) | Fremgangsmate for behandling av diabetes | |
DE602006003094D1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit | |
DK1678085T3 (da) | Fluidbehandlingsindretning | |
NO20052471D0 (no) | Fremgangsmate for fremstilling av 3-metyltiopropanal. | |
NO20034123L (no) | Fremgangsmåte for behandling av brennstoff | |
NO20054034D0 (no) | Fremgangsmate for behandling av hypotyroidisme. | |
DK1689706T3 (da) | Alfa, beta-umættede sulfoxider til behandling af proliferative forstyrrelser | |
DK2845594T3 (da) | Anvendelse af dihydroimidazoloner til behandlingen af hunde. | |
NO20053189D0 (no) | HVC-kombinasjonsterapi. | |
ITMI20030346A1 (it) | Procedimento per la produzione di mesitilene. | |
ITMO20030324A1 (it) | Apparato medicale. | |
IS8477A (is) | Beta-laktöm til að meðhöndla MTK sjúkdóma | |
NL1025908A1 (nl) | Farmaceutische combinatie. | |
ITBO20030521A1 (it) | Endoscopio per uso oculistico. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |